JER5:XETRA:XETRA-JPMorgan ETFs Ireland ICAV - EUR Corporate Bond 1-5 yr Research Enhanced Index ESG UCITS ETF EUR Acc (EUR)

ETF | Others |

Last Closing

USD 106.095

Change

-0.03 (-0.02)%

Market Cap

N/A

Volume

251.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-1.87 (-4.25%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-4.83 (-4.92%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-1.19 (-5.21%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.49 (-3.83%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.28 (-5.29%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.93 (-4.19%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.70 (-5.54%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-1.37 (-2.45%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.34 (-3.39%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.03 (-0.02%)

USD 12.26B

ETFs Containing JER5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.69% 66% D+ 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.69% 67% D+ 62% D
Trailing 12 Months  
Capital Gain 4.65% 54% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.65% 56% F 55% F
Trailing 5 Years  
Capital Gain 7.96% 28% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.96% 28% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain 0.41% 25% F 28% F
Dividend Return 0.41% 24% F 26% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.79% 89% A- 91% A-
Risk Adjusted Return 8.62% 25% F 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.